Andrew Lover

Associate Professor of Epidemiology and Deputy Director, New England Center of Excellence in Vector-Borne Disease University of Massachusetts Amherst

  • Amherst MA

Andrew Lover is an infectious disease epidemiologist whose work focuses on malaria and other vector-borne diseases.

Contact

University of Massachusetts Amherst

View more experts managed by University of Massachusetts Amherst

Expertise

Tick-borne Diseases
Infectious Disease
Vector-Borne Diseases
Drug Development
Malaria

Biography

Andrew Lover's work focuses on the development of novel tools for disease surveillance and development/optimization of new applications for existing therapeutics in vector-borne disease.

Lover has done field work in diverse global settings, including studies in Timor-Leste (East Timor), Cambodia, Vietnam, Laos and Kenya. He also has nearly a decade of experience as a drug discovery chemist, with research in respiratory therapeutics, novel antibiotics and inflammation targets.

Social Media

Video

Education

National University of Singapore

Ph.D.

National University of Singapore

M.P.H.

University of California, Santa Barbara

M.S.

Show All +

Select Recent Media Coverage

It’s mosquito season in Western Massachusetts and experts are monitoring it in the Pioneer Valley

WAMC  radio

2024-07-17

Andrew Lover, associate professor of epidemiology at UMass Amherst, discusses monitoring mosquitos in the Pioneer Valley. “This is exactly why we do public health surveillance,” he says. “This helps us understand where the virus is circulating, and then we can do more targeted surveillance and vector control in those areas.”

View More

As masks come off, experts warn the pandemic isn't over

WGBH  online

2023-03-11

"In many ways, we got lucky with Omicron," said epidemiologist Andrew Lover of UMass Amherst. "There's no reason to think that newer variants will be as mild. We all hope that that will stay the case. But we can't bank on it, necessarily."

View More

Coronavirus forecasting: UMass device may help identify future trends

Mass Live  online

2023-02-21

“We have the initial validation that the coughing indeed has a correlation with influenza-related illness,” Lover says. “Now we want to validate it beyond this specific hospital setting and show that we can generalize across locations.”

View More

Show All +

Select Publications

Measuring effects of ivermectin-treated cattle on malaria vectors in Vietnam: a village-randomized trial

medRxiv

2023

Background
Malaria elimination using current tools has stalled in many areas. Ivermectin (IVM) is a broad-antiparasitic drug and mosquitocide that has been proposed as a tool for reaching malaria elimination. Under laboratory conditions, IVM has been shown to reduce the survival of Anopheles populations that have fed on IVM-treated mammals. Treating cattle with IVM has been proposed as an important contribution to malaria vector management, however, the impacts of IVM in this animal health use-case had been untested in field trials in Southeast Asia.

View more

COVID-19 exposes weaknesses in public health in the Peruvian Amazon and highlights opportunities for a One Health approach

CABI One Health

2023

The Amazon is home to important wildlife and a biodiversity hotspot of global importance. The ancestral knowledge kept by Indigenous communities about its fauna and flora contributes further to its irreplaceable value. The Peruvian Amazon was heavily struck by the COVID-19 epidemic with a cumulative incidence of 725, a mortality rate of 34 per 100,000 inhabitants, and a case fatality rate of 4.6% by the end of July 2020. In this work, we review scientific literature and media to trace the events that happened at the beginning of the COVID-19 epidemic in the Peruvian Amazon.

View more

Characterizing the spatial distribution of multiple malaria diagnostic endpoints in a low-transmission setting in Lao PDR

Current Research on Serological Analyses of Infectious Diseases

2023

Through an intensification of their programmatic activities and an increased coverage of interventions (1), the Lao People’s Democratic Republic (PDR) has seen substantial declines in malaria cases, with a fall in case incidence by 80% from 2016 to 2020, and no reported malaria deaths since 2018 (2). Transmission is very low in northern Lao PDR, with P. vivax cases making up the majority of malaria burden (1, 3). The nation aims to eliminate Plasmodium vivax and Plasmodium falciparum from northern areas by 2025, and all species nationwide by 2030 (2, 4). As countries near elimination and transmission declines, they experience characteristic shifts in malaria epidemiology. Substantial areas become malaria-free, and malaria risk becomes increasingly heterogenous and geographically or demographically clustered (5, 6), with cases becoming more difficult to detect and diagnose.

View more

Show All +